Understanding Peptide Dosing Units (mg vs mcg vs IU)
Most peptide dosing confusion starts with units, so let's fix that first. Peptides are quantified by mass: milligrams (mg) in the vial, micrograms (mcg) in the protocol. The conversion between them is fixed and universal — 1 mg = 1,000 mcg. A study calling for 250 mcg is asking for 0.25 mg of peptide, no matter how it's dissolved. Standard pharmacology references, including texts like Goodman & Gilman's *The Pharmacological Basis of Therapeutics*, treat this as bedrock: dilution changes concentration, never the amount of compound in the syringe.
International units (IU) are a different animal entirely. An IU measures biological activity, defined against international reference standards for a specific substance, and the mass-to-IU relationship differs for every compound. There is no generic IU-to-mg conversion, and deriving one yourself is a reliable path to a tenfold error. If a supplier's datasheet expresses potency in IU, use the conversion stated for that product and lot — nothing else.
One more expert-level detail: check the net peptide content on your certificate of analysis. Lyophilized peptides often ship as TFA or acetate salts with residual moisture and counterions, so gross vial weight can overstate actual peptide. A "5 mg" vial may contain slightly less true peptide by mass. Work from net peptide weight when calculating doses — it's the number that determines what your model actually receives. (A scope note before we continue: this guide is a laboratory planning reference, not clinical dosing advice.)
Syringe Types and Unit Markings
Two syringe families matter for peptide work. The first is the U-100 insulin syringe, calibrated so that 1 mL equals 100 units — meaning 1 unit = 0.01 mL. These come in 0.3 mL, 0.5 mL, and 1 mL capacities, and many 0.3 mL versions add half-unit graduations (0.005 mL) for small draws. The second is the tuberculin (TB) syringe, a 1 mL syringe marked in 0.01 mL increments that reads directly in volume with no unit conversion layer at all.
Here is the distinction that prevents most errors: on a U-100 syringe, "units" describe volume, not drug amount. The same 10-unit mark holds 250 mcg, 50 mcg, or 2,500 mcg depending entirely on the concentration in the vial. Researchers moving between vials with different reconstitution volumes get burned by this constantly — the marking didn't change, but the dose it delivers did.
For selection, match the syringe to the draw size. Small-volume research injections commonly use 0.3 mL U-100 syringes with fine-gauge needles (29–31G is typical for subcutaneous-style administration in animal models), where half-unit marks help with tight targets. Low dead-space syringes reduce holdup volume, which matters when a single dose represents a meaningful fraction of the vial. Whatever you choose, commit to one syringe type for the entire study. Switching between U-100 unit markings and TB milliliter markings mid-project is a classic source of tenfold errors.
How Reconstitution Volume Affects Your Draw
Reconstitution volume sets concentration, and concentration determines what every syringe mark means. The math is two steps. First: concentration (mcg/mL) = vial mass in mg × 1,000 ÷ diluent volume in mL. Second: draw volume (mL) = target dose in mcg ÷ concentration. On a U-100 syringe, multiply mL by 100 to get units.
Worked example: a 5 mg vial reconstituted with 2 mL of bacteriostatic water gives 5,000 mcg ÷ 2 mL = 2,500 mcg/mL. A 250 mcg target therefore requires 250 ÷ 2,500 = 0.1 mL, which is 10 units on a U-100 syringe. Reconstitute that same vial with 5 mL instead and you get 1,000 mcg/mL — 10 mcg per unit — so 250 mcg becomes a 25-unit draw. More diluent means larger, easier-to-read draws; less diluent means every graduation line carries more dose.
Two nuances deserve attention. First, lyophilized powder occupies space: adding 2 mL of water yields slightly more than 2 mL of solution. At typical research concentrations the discrepancy is negligible, but at high concentrations it isn't — check whether the manufacturer's reconstitution guidance accounts for powder displacement. Second, diluent choice matters. Manufacturer reconstitution guidelines generally specify bacteriostatic water (0.9% benzyl alcohol) for vials that will be entered repeatedly, and sterile water for immediate single-use; some peptides have diluent-specific sensitivities, so follow the datasheet. Reconstitute by letting the diluent run down the vial wall and swirling gently — never shake.
A practical rule of thumb: pick a diluent volume that puts your routine dose at or above the 10-unit mark. Below that, you're reading a single graduation line, and a small bubble or parallax error becomes a large percentage of the dose.
Building a Repeatable Dosing Routine
Accuracy is mostly a systems problem, not a math problem. At the moment of reconstitution, label the vial completely: peptide name, net mass, diluent volume, resulting concentration in mcg/mL, date, and the precomputed draw for your standard dose in both mL and syringe units. Do the arithmetic once, on paper, away from the time pressure of a scheduled injection — not with the syringe in hand.
Then standardize the draw technique itself. Swab the stopper with alcohol, inject air equal to the intended draw volume to relieve vial vacuum, invert, and draw slowly. Tap any bubbles to the hub and expel them, then verify the meniscus against the mark at eye level. Trapped bubbles and unaccounted dead-space air are the two most common silent errors in peptide dosing, and both are eliminated by habit rather than vigilance.
Finally, keep a dosing log: vial ID, draw administered, date and time, and any deviation from protocol. Consistency across a study — same syringe model, same diluent volume, same technique, same personnel where possible — removes variables that would otherwise confound your data. Store reconstituted vials refrigerated (typically 2–8 °C) and follow the supplier's stability and handling guidance for the specific peptide. Bacteriostatic diluent supports multi-entry use, but it does not make an inherently unstable peptide stable; the datasheet, not habit, sets the shelf-life expectations.
When to Recalculate (New Vial, New Water Volume)
Recalculate whenever any input to the concentration equation changes. A new vial is the obvious trigger: net mass can vary between lots, and a 5.2 mg vial reconstituted with 2 mL is 2,600 mcg/mL, not the 2,500 mcg/mL on your old label. A new diluent volume is the second trigger — even 1 mL of difference shifts what every syringe mark delivers. A new peptide or salt form is the third, because net peptide content changes the effective mass you're actually drawing.
Also recalculate when the syringe changes. U-100 unit markings and TB milliliter markings are related by a fixed conversion — 1 unit = 0.01 mL — but converting in your head at the bench is exactly how errors happen. Write the conversion on your protocol sheet so it never lives in memory.
A six-step checklist covers every case: (1) confirm net peptide mass from the new vial's certificate of analysis; (2) confirm diluent volume; (3) compute concentration in mcg/mL; (4) compute the draw in mL and syringe units; (5) write both numbers on the vial label; (6) have a second person verify if your lab's procedures require it. Ninety seconds of arithmetic prevents the two classic failures — the overdose from treating syringe units as mcg, and the underdose from drawing against a stale concentration label. Treat every vial change as a new calculation, and the math stays boring, which is exactly what you want in research.